Abbott LaboratoriesABTNYSE
Loading
EBITDA Margin Over TimeStable
Percentile Rank79
3Y CAGR-1.5%
5Y CAGR+0.0%
Year-over-Year Change
EBITDA as a percentage of revenue
3Y CAGR
-1.5%/yr
vs +4.9%/yr prior
5Y CAGR
+0.0%/yr
Consistent
Acceleration
-6.3pp
Decelerating
Percentile
P79
Within normal range
vs 5Y Ago
1x
Modest growth
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 26.06% | +0.9% |
| 2024 | 25.83% | -2.3% |
| 2023 | 26.44% | -2.9% |
| 2022 | 27.23% | -3.5% |
| 2021 | 28.23% | +8.5% |
| 2020 | 26.01% | +4.9% |
| 2019 | 24.79% | +10.2% |
| 2018 | 22.50% | +0.5% |
| 2017 | 22.39% | +52.1% |
| 2016 | 14.72% | - |